Literature DB >> 910251

Sensitive radioimmunoassay for digoxin in plasma and urine.

J G Wagner, M R Hallmark, E Sakmar, J W Ayres.   

Abstract

A reproducible and sensitive radioimmunoassay for digoxin in either serum, plasma or urine is described. Using 0.5 ml of serum or plasma, the assay sensitivity is 0.05 ng of digoxin/ml. The antiserum and tracer solutions employed are available in a kit sold in the United States. All other reagents were prepared in the laboratory. The assay allows measurement of digoxin in plasma or serum for 96 hours after single 0.5 mg doses of digoxin; this is necessary in human bioavailability studies to accurately estimate the total area under the digoxin concentration, time curve from zero to infinite time. In contrast, with the kit assay, employing 0.2 ml of plasma or serum, it has been reported that the 12 hr serum digoxin levels, after single 0.5 mg doses, are, in most subjects, below the sensitivity limit (about 0.5 ng/ml) of the assay.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 910251     DOI: 10.1016/0039-128x(77)90122-2

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  3 in total

1.  Comparison of the in vitro and in vivo release of digoxin from four different soft gelatin capsule formulations.

Authors:  J G Wagner; R G Stoll; D J Weidler; J W Ayres; M R Hallmark; E Sakmar; A Yacobi
Journal:  J Pharmacokinet Biopharm       Date:  1979-04

2.  Bioavailability assessment: methods to estimate total area (AUC O to infinity) and total amount excreted (A infinity e) and importance of blood and urine sampling scheme with application to digoxin.

Authors:  J G Wagner; J W Ayres
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

3.  Evidence of nonlinearity in digoxin pharmacokinetics.

Authors:  J G Wagner; K D Popat; S K Das; E Sakmar; H Movahhed
Journal:  J Pharmacokinet Biopharm       Date:  1981-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.